MHRA position on unlicensed medicines sold direct to the public

Placeholder seed entry recording the source, not an event. The UK regulator has published guidance and enforcement positions on the supply of unlicensed medicines to the public, including substances marketed as research chemicals. Several compounds tracked here have been the subject of public statements. PepIndex records those affecting indexed compounds.